Jeong-Hwan Hwang

Dr. Jeong-Hwan Hwang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SPSang-Won Park
Sang-Won Park
CLChang-Seop Lee
Chang-Seop Lee
JKJeong-Han Kim
Jeong-Han Kim
IBIn-Gyu Bae
In-Gyu Bae
CMChisook Moon
Chisook Moon
MOMyoung-Don Oh
Myoung-Don Oh
Severe fever with thrombocytopenia syndrome (SFTS) is emerging in Asian 3 countries, China, Japan and Korea, which are scrub typhus endemic areas, and its incidence is increasing. As the two infections overlap epidemiologically and clinically and the accessibility or sensitivity of diagnostic tests is limited, early clinical prediction may be useful for diagnostic and therapeutic purposes. Patients aged ≥16 years who were clinically suspected and laboratory-confirmed to be infected with Orientia tsutsugamushi or the SFTS virus in South Korea were enrolled. Clinical and laboratory parameters were compared. Scrub typhus was further subclassified according to the status of eschar and skin rash. An SFTS prediction scoring tool was generated based on a logistic regression analysis of SFTS compared with scrub typhus. The analysis was performed on 255 patients with scrub typhus and 107 patients with SFTS. At initial presentation, subjective symptoms except for gastrointestinal symptoms, were more prominent in scrub typhus patients. In addition to the characteristic eschar and skin rash, headache was significantly more prominent in scrub typhus, while laboratory abnormalities were more prominent in SFTS. Leukopenia (white blood cell count < 4000/mm3; odds ratio [OR] 30.13), thrombocytopenia (platelet count < 80,000 /mm3; OR 19.73) and low C-reactive protein (< 1 mg/dL; OR 67.46) were consistent risk factors for SFTS (all P < 0.001). A prediction score was generated using these 3 variables, and a score ≥ 2 had a sensitivity of 93.1% (95% confidence interval [CI], 87.9–96.4%) and a specificity of 96.1% (95% CI, 93.8–97.6%) for SFTS. This prediction scoring tool may be useful for differentiating SFTS from eschar- or skin rash-negative scrub typhus. It is a simple and readily applicable tool with potential for use in primary care settings.

30 June 2016 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
DHDae‐Hyuk Heo
Dae‐Hyuk Heo
DBDae‐Youb Baek
Dae‐Youb Baek
SOSang‐Min Oh
Sang‐Min Oh
JHJoo‐Hee Hwang
Joo‐Hee Hwang
CLChang‐Seop Lee
Chang‐Seop Lee
JHJeong-Hwan Hwang
Jeong-Hwan Hwang

1 September 2020 in Journal of Ginseng Research
Verified
Journal Article
Open access
JHJeong-Hwan Hwang
Jeong-Hwan Hwang
SPSoo-Hyun Park
Soo-Hyun Park
ECEun-Kyung Choi
Eun-Kyung Choi
SJSu-Jin Jung
Su-Jin Jung
MPMi Kyung Pyo
Mi Kyung Pyo
SCSoowan Chae
Soowan Chae
GS-3K8 and GINST, both of which are modified ginseng extracts, have never been examined in terms of their effectiveness for the prevention of acute respiratory illness (ARI) in humans. We conducted a pilot study to assess the feasibility of performing a large-scale, randomized, controlled trial. This study was a randomized, double-blind, placebo-controlled, pilot study at a single center from October 2014 to March 2015. The 45 healthy applicants were randomly divided into the GS-3K8 (n = 15), GINST (n = 15), and placebo groups (n = 15). The study drug was administered as a capsule (500 mg/cap and 3000 mg/day). GS-3K8 contained 6.31 mg/g of Rg1, 15.05 mg/g of Re, 30.84 mg/g of Rb1, 15.02 mg/g of Rc, 12.44 mg/g of Rb2, 6.97 mg/g of Rd, 1.59 mg/g of Rg3, 3.25 mg/g of Rk1, and 4.84 mg/g of Rg5. GINST contained 7.54 mg/g of Rg1, 1.87 mg/g of Re, 5.42 mg/g of Rb1, 0.29 mg/g of Rc, 0.36 mg/g of Rb2, 0.70 mg/g of Rd, and 6.3 mg/g of compound K. The feasibility criteria were the rates of recruitment, drug compliance, and successful follow-up. The primary clinical outcome measure was the incidence of ARI. The secondary clinical outcome measures were the duration of symptoms. The rate of recruitment was 11.3 participants per week. The overall rate of completed follow-up was 97.8%. The mean compliance rate was 91.64 ± 9.80%, 95.28 ± 5.75%, and 89.70 ± 8.99% in the GS-3K8, GINST, and placebo groups, respectively. The incidence of ARI was 64.3% (9/14; 95% confidence interval [CI], 31.4–91.1%), 26.7% (4/15; 95% CI, 4.3–49.0%), and 80.0% (12/15; 95% CI, 54.8–93.0%) in the GS-3K8, GINST, and placebo groups, respectively. The average days of symptoms were 3.89 ± 4.65, 9.25 ± 7.63, and 12.25 ± 12.69 in the GS-3K8, GINST, and placebo groups, respectively. The results support the feasibility of a full-scale trial. GS-3K8 and GINST appear to have a positive tendency toward preventing the development of ARI and reducing the symptom duration. A randomized controlled trial is needed to confirm these findings.

4 May 2022 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
JYJeong-Seop Yoo
Jeong-Seop Yoo
DKDain Kim
Dain Kim
HCHye-Yeon Choi
Hye-Yeon Choi
SYSunjong Yoo
Sunjong Yoo
JHJoo-Hee Hwang
Joo-Hee Hwang
CLChang-Seop Lee
Chang-Seop Lee
: Eschar is used to establish the clinical diagnosis of scrub typhus. To identify the prevalence of eschar and its location in scrub typhus, we reviewed globally published peer-reviewed articles. We conducted a systematic literature review, using publications extracted from PubMed from January 1943 to August 31, 2019 with the keywords “scrub typhus” or “tsutsugamushi.” We collected articles associated with eschar prevalence and distribution in scrub typhus infection and reported on the body locations of eschar. A total of 458 articles containing information on the prevalence, geographical distribution, and body distribution of eschar were used for this review. The overall prevalence rate of eschar was 58.0% with the greatest prevalence in East Asia (78.7%) followed by Oceania (52.2%), Southeast Asia (41.4%), and then the lowest in South Asia (32.8%). The frequency of eschar distribution was highest in the inguinal area (28.5%), followed by the anterior area (28.0%), and the lower extremities (22.0%). The upper extremities (8.9%), back (6.6%), and head and neck (6.1%) regions had relatively low frequencies of distribution. We identified the prevalence of eschar differed by geographic locations and anatomical sites on the patient of scrub typhus.

25 February 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
HWHyun Ji Woo
Hyun Ji Woo
TKTae-Kyu Kwon
Tae-Kyu Kwon
SHSang Taek Heo
Sang Taek Heo
Jeong Rae YooJeong Rae Yoo
Jeong Rae Yoo
MKMisun Kim
Misun Kim
MKMin-Gul Kim
Min-Gul Kim
Background and aim: Severe fever with thrombocytopenia syndrome (SFTS) is a fatal tick-borne infectious disease lacking effective treatments or vaccines. Early identification of prognostic factors is essential for optimizing clinical management. This study investigated the predictors for mortality in SFTS patients. Methods: We conducted a retrospective multicenter cohort study of 413 SFTS patients hospitalized in South Korea from 2013 to 2024. Clinical and laboratory data were comprehensively analyzed to evaluate associations between in-hospital mortality and various inflammatory, immune, and nutritional biomarkers. Cox regression and time-dependent receiver operating characteristic (ROC) analyses were performed to identify risk factors. Results: 413 patients diagnosed with SFTS were included and In-hospital mortality was 17% (70/413). Multivariate Cox regression identified older age (HR: 1.042; 95% CI: 1.014–1.071), elevated PT(INR) (HR: 109.57; 95% CI: 19.79–606.57), and lower prognostic nutritional index (PNI) (HR: 0.937; 95% CI: 0.886–0.990) as early predictors of mortality. Time-dependent ROC analysis demonstrated predictive accuracy, with AUCs of 0.512 for age, 0.857 for PT(INR), and 0.694 for PNI at 30 days. Kaplan-Meier analysis revealed significant survival differences for patients stratified by PNI (< 40.75), PT(INR) (≥ 0.97), and age (≥ 59 years). Conclusions: PNI, PT(INR), and age were identified as key early predictors of mortality in SFTS. PNI, as a novel biomarker, was found to be a useful index for risk level and treatment strategies in SFTS patients. Clinical trial number: Not applicable.

1 December 2021 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
JHJoo-Hee Hwang
Joo-Hee Hwang
JHJeong-Hwan Hwang
Jeong-Hwan Hwang
CLChang-Seop Lee
Chang-Seop Lee
: Scrub typhus is an acute febrile disease caused by Orientia tsutsugamushi, which is transmitted through chigger mites. Delayed treatment results in various complications and, in severe cases, death. Granzymes are secreted by cytotoxic T lymphocytes or natural killer cells and are known to play an important role in controlling intracellular pathogens. To date, few studies have been done on granzymes in patients with scrub typhus. In this study, granzymes A and B showed a significant increase during the acute stage of scrub typhus compared with healthy control subjects, and decreased sharply after treatment. In addition, granzymes A and B were significantly high in the moderately elevated liver enzyme group. In conclusion, it appears that the host during the acute phase of scrub typhus increases cytotoxic T-cell activity to control infection.